查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
複合藥房市場，按產品類型、按應用、按治療領域、按複合類型、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1351423

複合藥房市場，按產品類型、按應用、按治療領域、按複合類型、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Compounding Pharmacies Market, By Product Type, By Application, By Therapeutic areas, By Compounding Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 248 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年，複合藥局市場規模為 126.087 億美元，2023 年至 2030 年年複合成長率為 6.3%。

複合藥局市場 - 市場動態：

  • 慢性病盛行率上升、老年人口增加以及預期壽命延長預計將推動市場需求
  • 慢性疾病通常需要長期治療。複方藥房可以根據患者的獨特需求調整藥物，最大限度地提高劑量和劑型，或以其他方式提高藥物的有效性或對有特殊需求的患者的耐受性。根據國家衛生委員會的數據，慢性病通常無法治癒且持續存在，影響約 1.33 億美國人，佔全國總人口的 40% 以上。到 2020 年，這一數位預計將成長至約 1.57 億，其中 8,100 萬人患有多種疾病。由於老年人越來越多，因此對專業老年護理的需求更大，無論是在針對該年齡層設計的醫療服務還是設施方面。隨著預期壽命的延長，對確保生活品質的預防醫學的重視也隨之增加。這可能會加強健康、營養和篩檢產業。發展中國家提供了重要的發展機會。隨著這些領域的意識和收入水準的提高，對客製化治療的需求可能會增加。然而，複方藥局偶爾遇到的嚴格監管可能會帶來問題。它阻礙了市場的成長。

複合藥房市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，全球複合藥局市場預計在預測期內（2023-2030 年）每年將以 6.3% 左右的年複合成長率成長
  • 由於人們對永續成長的認知不斷增強，複合製藥產業預計將以顯著的速度成長
  • 根據產品類型細分，預計 Oral 將在 2022 年顯示最大的市場佔有率
  • 根據治療領域細分，荷爾蒙替代療法（HRT）是2022年的主導類型
  • 從應用細分來看，2022年老年醫學為主導類型
  • 按地區分類，北美是 2022 年的主要收入來源

複合藥房市場細分分析：

  • 全球複合藥房市場根據產品類型、治療領域、應用、複合類型和地區進行細分。
  • 根據產品類型，市場分為七類：口服、外用、直腸、腸外、鼻腔、眼科和漱口水。口腔細分市場佔據主導地位。由於其給藥方便、患者依從性以及劑型的多樣性（如片劑、膠囊、液體和混懸劑），口服途徑仍然是最受歡迎的給藥方式之一。
  • 市場根據治療領域分為四大類：疼痛管理、荷爾蒙替代療法（HRT）、皮膚科和特殊藥物。荷爾蒙替代療法（HRT）細分市場佔據主導地位。複方藥局在荷爾蒙替代療法（HRT）領域發揮重要作用。 HRT 是使用荷爾蒙來治療體內荷爾蒙異常，這種異常通常與更年期、男性更年期（有時稱為「男性更年期」）或某些內分泌疾病有關。
  • 依應用市場分為四大類：兒科、成人、老年和獸醫。老年應用程式在市場上佔據主導地位，並可能在預測期內保持其主導地位。複方藥局在老年保健領域發揮重要作用。由於多重用藥（服用多種藥物）、與年齡相關的生理變化、特定藥物敏感性和藥物管理問題等因素，老年人群經常有獨特的處方需求。

複合藥局市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。由於該地區對複合藥物的認知較高以及醫療機構數量不斷增加，預計北美將主導市場的成長。多年來，美國和加拿大在醫療基礎設施方面進行了大量投資。這不僅涵蓋醫院，還涵蓋專科診所、療養院和其他複合藥物可能有益的護理機構。 《全球視野下的美國醫療保健》預測，2021年，美國醫療保健支出佔國內生產毛額（GDP）的17.8%，幾乎是經合組織國家平均水準的兩倍。由於認知度高、監管明確、經濟實力強和技術創新，歐洲是複方藥房的第二大市場。

複合藥局市場-競爭格局：

與許多行業一樣，複方藥房行業的競爭格局是由許多主要參與者、區域參與者和本地獨立藥房的存在決定的。這些組織經常在品質、服務範圍、法規遵循、技術改進和地理覆蓋範圍等方面進行競爭。市場佔有率將根據每個公司佔據的位置和複合領域的具體利基而有所不同。就收入而言，儘管當地獨立藥局可能在當地市場中佔有主要佔有率，但擁有多個地點的大型企業可能會佔據主導地位。

一些藥房可能會利用技術改進來提高配製精度、品質控制或營運效率。例如，Avella Specialty Pharmacy 簽署了一項最終協議，收購總部位於休士頓的Advanced Pharma Inc.，這是一家在FDA 註冊的503B 外包機構，為全國醫院、衛生系統和門診手術中心提供14 個治療類別的複合產品。

最近的發展：

2018年10月11日，費森尤斯·卡比宣布目前已在安大略省密西索加開設了一個新的藥物配製中心。該中心擁有最先進的製造技術和工藝，旨在滿足嚴格的品質標準和客戶不斷成長的產能需求。該工廠為加拿大醫院生產複方藥物。

目錄

第 1 章：複合藥局市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的複方藥房市場片段
    • 按應用分類的複合藥房市場片段
    • 按複合類型分類的複合藥房市場片段
    • 按治療領域分類的複合藥房市場片段
    • 按國家/地區分類的複合藥房市場片段
    • 按地區分類的複合藥房市場片段
  • 競爭洞察

第 3 章：複合藥局主要市場趨勢

  • 複合藥房市場驅​​動因素
    • 市場促進因素的影響分析
  • 加劇藥房市場限制
    • 市場限制影響分析
  • 複合藥房市場機會
  • 複合藥局市場未來趨勢

第 4 章：複合藥局產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：複合藥局市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：複合藥局市場格局

  • 2022 年複方藥局市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：複合藥局市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 口服
      • 膠囊
      • 平板電腦
      • 混合物
      • 棒棒糖
      • 含片
    • 專題
      • 凝膠
      • 藥膏
      • 奶油
      • 乳液
    • 直腸
    • 注射用
    • 鼻腔
    • 眼科
    • 漱口水

第 8 章：複合藥局市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 兒科
    • 成年人
    • 老年科
    • 獸醫

第 9 章：複合藥局市場 - 按複方類型

  • 概述
    • 按複合類型分類的細分市場佔有率分析
    • 藥物成分變更 (PIA)
    • 目前無法使用的藥品製造 (CUPM)
    • 藥物劑量變更 (PDA)
    • 其他

第 10 章：複合藥房市場 - 按治療領域

  • 概述
    • 按應用的細分市場佔有率分析
    • 疼痛管理
    • 荷爾蒙替代療法 (HRT)
    • 皮膚科
    • 特殊藥物

第 11 章：複合藥局市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美複合藥屋主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按複合類型）
    • 北美市場規模與預測（按治療領域）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲複方藥屋主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模與預測（按複利類型）
    • 歐洲市場規模與預測（按治療領域）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區複方藥局主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模與預測（依複利類型）
    • 按治療領域分類的亞太市場規模和預測
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲複合藥屋主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按複合類型）
    • 拉丁美洲市場規模與預測（按治療領域）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲複合藥屋主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按複合類型）
    • 中東和非洲市場規模及預測（按治療領域）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 複合藥局產業

  • 競爭儀表板
  • 公司簡介
    • Avella Specialty Pharmacy
    • Central Admixture Pharmacy Services
    • Fagron
    • Fresenius Kabi AG
    • PharMEDium Services
    • Institutional Pharmacy Solutions
    • Cantrell Drug Company
    • Triangle Compounding Pharmacies
    • Lorraine's Pharmacy
    • Rx3 Compounding Pharmacy
    • B Braun Melsungen AG
    • Clinigen Group PLC
    • QuVa Pharma
    • ITC Compounding Pharmacy
    • Advanced Pharmacy.

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1658

REPORT HIGHLIGHT

Compounding Pharmacies Market size was valued at USD 12,608.7 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.

Compounding pharmacies have a unique and crucial function in the pharmaceutical sector. By blending, modifying, or combining two or more substances to match a patient's unique needs, pharmacists create customized prescriptions for their patients. In order to create a compounded medicine, compounding pharmacies must use only pure, pharmaceutical-grade ingredients. These have to be manufactured in a setting that has an FDA registration. Compound and conventional medications are labeled differently in several cases. unlike labels for FDA-approved pharmaceuticals, compounded medicine labels don't adhere to a specific structure. The laws governing them differ as well.

Compounding Pharmacies Market - Market Dynamics:

  • Increasing prevalence of chronic disease, increase in old age population, and improved life expectancy expected to propel market demand
  • Long-term treatment is frequently necessary for chronic disorders. Compounding pharmacies can adapt pharmaceuticals to a patient's unique requirements, maximizing dosages and forms, or otherwise improving their effectiveness or tolerability for patients with particular demands. According to the National Health Council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. There is a greater need for specialist geriatric care as there are more senior people, both in terms of medical services and facilities designed for this age group. The emphasis on preventative medicine to ensure quality of life grows as life expectancy rises. This may strengthen the wellness, nutrition, and screening industries. Significant opportunity for development is offered by developing nations. The need for customized treatments could increase as awareness and income levels improve in these areas. However, the severe regulatory supervision that compounding pharmacies occasionally experience can be problematic. It hampers the market growth.

Compounding Pharmacies Market - Key Insights:

  • As per the analysis shared by our research analyst, the global Compounding Pharmacies market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2023-2030)
  • The Compounding Pharmacies industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Product type segmentation, Oral was predicted to show maximum market share in the year 2022
  • Based on Therapeutic Area segmentation, Hormone Replacement Therapy (HRT) was the leading type in 2022
  • Based on Application segmentation, Geriatric was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Compounding Pharmacies Market- Segmentation Analysis:

  • The Global Compounding Pharmacies Market is segmented based on Product Type, Therapeutic Areas, Application, Compounding Type, and Region.
  • The market is divided into seven categories based on product type: Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, and Mouthwashes. The oral segment dominates the market. Due to its ease of administration, patient compliance, and diversity in formulation (such as tablets, capsules, liquids, and suspensions), the oral route remains one of the most popular drug delivery modalities.
  • The market is divided into four categories based on Therapeutic Areas: Pain Management, Hormone Replacement Therapy (HRT), Dermatology, and Specialty Drugs. Hormone Replacement Therapy (HRT) segment dominates the market. Compounding pharmacies play an important part in the field of Hormone Replacement Therapy (HRT). HRT is the use of hormones to treat hormonal abnormalities in the body, which are frequently associated with menopause, andropause (sometimes known as "male menopause"), or certain endocrine illnesses.
  • The market is divided into four categories based on Application: Pediatric, adult, Geriatric, and Veterinary. The Geriatric application dominates the market and is likely to maintain its dominance during the forecast period. Compounding pharmacies play an important part in the geriatric healthcare sector. Because of factors such as polypharmacy (taking numerous medications), age-related physiological changes, specific drug sensitivities, and drug administration problems, the aged population frequently has unique prescription needs.

Compounding Pharmacies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to High regional awareness regarding compounding medications, and an increasing number of healthcare facilities. Over the years, the US and Canada have made considerable investments in healthcare infrastructure. This covers not only hospitals but also specialty clinics, nursing homes, and other care settings where compounded pharmaceuticals can be beneficial. The U.S. Health Care from a Global Perspective predicted that in 2021, the U.S. spent 17.8 percent of gross domestic product (GDP) on health care, nearly twice as much as the average OECD country. Europe is the second-largest market for Compounding Pharmacies, due to high awareness, regulatory clarity, economic strength, and technological innovation.

Compounding Pharmacies Market- Competitive Landscape:

As with many sectors, the competitive landscape of the compounding pharmacies industry is defined by the existence of many main players, regional players, and local, independent pharmacies. These organizations frequently compete on the basis of quality, service range, regulatory compliance, technical improvements, and geographic coverage. The market share will differ depending on the location and the precise niche within compounding that each company occupies. In terms of revenue, larger businesses with several locations may dominate, although local, independent pharmacies may hold major shares in local marketplaces.

Some pharmacies may use technology improvements to improve compounding precision, quality control, or operational efficiency. For Example, Avella Specialty Pharmacy has signed a definitive agreement to acquire Houston-based Advanced Pharma Inc., an FDA-registered 503B outsourcing facility providing compounded products across 14 therapeutic classes to hospitals, health systems, and ambulatory surgery centers nationwide.

Recent Developments:

On Oct. 11, 2018, Fresenius Kabi announced currently it has opened a new pharmaceutical compounding center in Mississauga, Ontario. The center features state-of-the-art manufacturing technology and processes designed to meet rigorous quality standards and increased capacity needs of customers. The facility produces compounded pharmaceuticals for Canadian hospitals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPOUNDING PHARMACIES MARKET KEY PLAYERS

  • Avella Specialty Pharmacy
  • Central Admixture Pharmacy Services
  • Fagron
  • Fresenius Kabi AG
  • PharMEDium Services
  • Institutional Pharmacy Solutions
  • Cantrell Drug Company
  • Triangle Compounding Pharmacies
  • Lorraine's Pharmacy
  • Rx3 Compounding Pharmacy
  • B Braun Melsungen AG
  • Clinigen Group PLC
  • QuVa Pharma
  • ITC Compounding Pharmacy
  • Advanced Pharmacy

GLOBAL COMPOUNDING PHARMACIES MARKET, BY PRODUCT TYPE

  • Oral
  • Capsule
  • Tablets
  • Mixtures
  • Lollipops
  • Lozenges
  • Topical
  • Gels
  • Ointments
  • Cream
  • Lotions
  • Rectal
  • Parenteral
  • Nasal
  • Ophthalmic
  • Mouthwashes

GLOBAL COMPOUNDING PHARMACIES MARKET, BY THERAPEUTIC AREA

  • Pain Management
  • Hormone Replacement Therapy (HRT)
  • Dermatology
  • Specialty Drugs

GLOBAL COMPOUNDING PHARMACIES MARKET, BY APPLICATION

  • Pediatric
  • Adults
  • Geriatric
  • Veterinary

GLOBAL COMPOUNDING PHARMACIES MARKET, BY COMPOUNDING TYPE

  • Pharmaceutical Ingredient Alteration (PIA)
  • Pharmaceutical Dosage Alteration (PDA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Others

GLOBAL COMPOUNDING PHARMACIES MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Compounding Pharmacies Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Compounding Pharmacies Market Snippet by Product Type
    • 2.1.2. Compounding Pharmacies Market Snippet by Application
    • 2.1.3. Compounding Pharmacies Market Snippet by Compounding Type
    • 2.1.4. Compounding Pharmacies Market Snippet by Therapeutic Areas
    • 2.1.5. Compounding Pharmacies Market Snippet by Country
    • 2.1.6. Compounding Pharmacies Market Snippet by Region
  • 2.2. Competitive Insights

3. Compounding Pharmacies Key Market Trends

  • 3.1. Compounding Pharmacies Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Compounding Pharmacies Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Compounding Pharmacies Market Opportunities
  • 3.4. Compounding Pharmacies Market Future Trends

4. Compounding Pharmacies Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Compounding Pharmacies Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Compounding Pharmacies Market Landscape

  • 6.1. Compounding Pharmacies Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Compounding Pharmacies Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Oral
      • 7.1.2.1. Capsule
      • 7.1.2.2. Tablets
      • 7.1.2.3. Mixtures
      • 7.1.2.4. Lollipops
      • 7.1.2.5. Lozenges
    • 7.1.3. Topical
      • 7.1.3.1. Gels
      • 7.1.3.2. Ointments
      • 7.1.3.3. Cream
      • 7.1.3.4. Lotions
    • 7.1.4. Rectal
    • 7.1.5. Parenteral
    • 7.1.6. Nasal
    • 7.1.7. Ophthalmic
    • 7.1.8. Mouthwashes

8. Compounding Pharmacies Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Pediatric
    • 8.1.3. Adults
    • 8.1.4. Geriatric
    • 8.1.5. Veterinary

9. Compounding Pharmacies Market - By Compounding Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Compounding Type, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical Ingredient Alteration (PIA)
    • 9.1.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
    • 9.1.4. Pharmaceutical Dosage Alteration (PDA)
    • 9.1.5. Others

10. Compounding Pharmacies Market - By Therapeutic Areas

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 10.1.2. Pain Management
    • 10.1.3. Hormone Replacement Therapy (HRT)
    • 10.1.4. Dermatology
    • 10.1.5. Specialty Drugs

11. Compounding Pharmacies Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Compounding Pharmacies Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Compounding Pharmacies Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Compounding Pharmacies Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Compounding Pharmacies Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Compounding Pharmacies Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Compounding Pharmacies Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Avella Specialty Pharmacy
    • 12.2.2. Central Admixture Pharmacy Services
    • 12.2.3. Fagron
    • 12.2.4. Fresenius Kabi AG
    • 12.2.5. PharMEDium Services
    • 12.2.6. Institutional Pharmacy Solutions
    • 12.2.7. Cantrell Drug Company
    • 12.2.8. Triangle Compounding Pharmacies
    • 12.2.9. Lorraine's Pharmacy
    • 12.2.10. Rx3 Compounding Pharmacy
    • 12.2.11. B Braun Melsungen AG
    • 12.2.12. Clinigen Group PLC
    • 12.2.13. QuVa Pharma
    • 12.2.14. ITC Compounding Pharmacy
    • 12.2.15. Advanced Pharmacy.

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Compounding Pharmacies Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Compounding Pharmacies Market, by Product Type 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Compounding Pharmacies Market, by Application 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Compounding Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Compounding Type
  • TABLE Global Compounding Pharmacies Market, by Compounding Type 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Therapeutic Areas Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Areas
  • TABLE Global Compounding Pharmacies Market, by Therapeutic Areas 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Compounding Pharmacies Market, by Region 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)

List of Figures

  • FIGURE Compounding Pharmacies Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Compounding Type segment market share analysis, 2022 & 2030
  • FIGURE Compounding Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapeutic Areas segment market share analysis, 2022 & 2030
  • FIGURE Therapeutic Areas segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Europe Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Asia Pacific Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Latin America Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Middle East and Africa Compounding Pharmacies Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE Germany Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE India Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE Brazil Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE Saudi Arabia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)